Navigation Links
Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association

WellPoint's PBM One of Only 13 Companies to Meet HRPA's Stringent Pricing

and Transparency Requirements

INDIANAPOLIS, Oct. 10 /PRNewswire/ -- WellPoint NextRx, the nation's largest health plan-owned pharmacy benefit management (PBM) subsidiary, has received Transparency in Pharmaceutical Purchasing Solutions (TIPPS) certification from the HR Policy Association (HRPA). Effective January 1, 2008, the certification will enable WellPoint NextRx to offer PBM services to customer members of the HRPA Pharmaceutical Purchasing Coalition, which is made up of more than 55 of the nation's largest employers and provides pharmacy benefits to more than five million Americans.

"WellPoint NextRx is committed to promoting transparency in our industry and our TIPPS certification is evidence of this commitment," said Renwyck Elder, president of WellPoint NextRx, a division of WellPoint, Inc. "We look forward to working with members of the HR Policy Association as well as other companies to help them better manage their pharmacy costs and develop benefit designs that bring the greatest possible value to their employees."

To be certified, WellPoint NextRx agreed to meet the following business standards:

-- To provide the acquisition price of brand and generic drugs

delivered by mail order

-- To charge employers the same price that WellPoint NextRx pays to the

dispensing pharmacy for brand and generic drugs dispensed at retail


-- To disclose and pass through any and all payments received by

WellPoint NextRx from pharmaceutical manufacturers that are based on

an employer's drug utilization

-- To allow an audit of contracts to verify compliance

Each year, the HRPA formulates a uniform definition of transparency and annually certifies organizations that agree to TIPPS standards. For 2008, HRPA has certified five new PBMs and recertified eight PBMs that have agreed to do business in a fully transparent manner.

"Full transparency makes it easier for employers, their employees, and their dependents to understand the true price of their medications to support more informative healthcare decisions," said Elder. "WellPoint NextRx has always been dedicated to full transparency and we are extremely proud that HRPA has recognized our efforts."

WellPoint NextRx is a service mark of WellPoint, Inc. (NYSE: WLP), services are provided by a WellPoint PBM (either Professional Claims Services Inc., doing business as WellPoint Pharmacy Management, or Anthem Prescription Management, LLC, as appropriate). WellPoint NextRx is a division of WellPoint, Inc.

About WellPoint, Inc.

WellPoint's mission is to improve the lives of the people it serves and the health of its communities. WellPoint, Inc. is the largest health benefits company in terms of commercial membership in the United States. Through its nationwide networks, the company delivers a number of leading health benefit solutions through a broad portfolio of integrated health care plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, pharmacy benefit management, dental, vision, behavioral health benefit services, as well as long term care insurance and flexible spending accounts. Headquartered in Indianapolis, Indiana, WellPoint is an independent licensee of the Blue Cross and Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Empire Blue Cross Blue Shield in 10 New York City metropolitan and surrounding counties and as Empire Blue Cross or Empire Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at

SOURCE WellPoint
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... by the University of Toronto and the University of British Columbia suggested that laws ... head injuries. The article explains that part of the reason for the controversial conclusion ...
(Date:11/27/2015)... ... , ... A team of Swiss doctors has released a report on mesothelioma ... posted the findings on the website. Click here to read the details now. ... patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... ... Herpes-only dating community in the world, revealed that over 50% of its members are under ... under the age of 50 – or 67% of the population - are infected with ... infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
Breaking Medicine Technology: